From spiraling claim volumes to more stringent payer requirements and increasing reporting obligations, today's health practitioners face higher challenges than ever. As a result, diagnostics providers across the country are effectively looking for new revenue streams, improved payer relations, cost-cutting opportunities, and more predictable reimbursement rates. For example, high-quality and carefully designed data sets facilitate improved analytics, and the use of Artificial Intelligence (AI) can expedite the Revenue Cycle Management (RCM) process while also enhancing financial and operational performance. Council for Affordable Quality Healthcare, Inc. (CAQH) used data from medical plans representing nearly half of the US insured population to find that electronic prior authorizations adoption rose by just one percentage point to 13 percent from 2018 to 2019. For years, visionary healthcare providers have been using technology to improve care for people suffering from sleep problems, eye illness, cancer, and now, even COVID-19.
In the dark of night, a drone takes off from a Toronto hospital rooftop, the hum of its rotors barely audible over the bustling sounds of the cars and pedestrians below in Canada's largest metropolis. On its maiden flight, with a bird's-eye view of the city's glistening skyline as it glides over apartments, shops and office towers, the drone is carrying a precious cargo -- human lungs for transplant. The 15.5-kilogram (34-pound) carbon fibre unmanned electric drone purpose-built by Quebec-based Unither Bioelectronics flew just 1.2 kilometers (0.75 miles) from Toronto Western Hospital on the city's west side to the roof of the downtown Toronto General Hospital. This handout photo released by Unither Bioelectronique and taken in September 2021 shows Unither Bioelectronique's drone transporting a pair of donor lungs, high above Toronto traffic at night Photo: Unither Bioelectronique / Jason van Bruggen The trip at the end of September took less than 10 minutes. It was automated but kept under the watchful eye of engineers and doctors.
The £1.4m funding is financed by the NHS' AI Lab – called NHSX – and The Health Foundation, with the projects aiming to utilise AI to address racial and ethnic health inequalities in the UK. The selected initiatives will implement the technology in a broad range of investigations, from assessing disparities in maternal health outcomes to designing standards and guidance to ensure AI systems are inclusive and generalisable. The NHS AI lab introduced the AI Ethics Initiative in March 2021 to assist research and practical interventions that enhance existing efforts to validate, evaluate, and regulate AI-based technologies in the healthcare sector to mitigate health inequalities. This considerable funding results from their partnership with The Health Foundation on a research competition, which the NIHR enabled. The endeavour saw the organisations collaborate to explore and create opportunities to employ AI to address health inequalities and optimise datasets to improve AI's development, testing, and deployment.
Following the successful use of online apps, tracking devices and telemedicine to control a pandemic, while enabling remote care, doctors in the Middle East have started using medtech gadgets for non-invasive as well as accurate procedures. Robots have been pitched as cops, office assistants and guides for the future, but the need for contactless healthcare has led to their adoption as support staff in hospitals, to monitor patients in quarantine. Robotic pharmacies have also become a feature at AI-backed facilities in the UAE, while droids have even conducted operations, one of which involved removal of a tumour. Considering the precision that smart machines bring to the table, robo-arms are now being used for removal and transfer of kidneys from donors to patients, at a hospital in Dubai. The surgeries that benefited two people were carried out using the state-of-the-art Da Vinci tool, which is a pair of robotic arms, that can imitate the movement of human hands.
Expanded partnerships, access to clinical trials, and new medical and behavioral treatments and interventions reaching individuals more quickly will benefit communities in Pennsylvania and beyond thanks to the renewal of Penn State's Clinical and Translational Science Award (CTSA) funded by the National Institutes of Health (NIH). The NIH's National Center for Advancing Translational Sciences (NCATS) awarded Penn State more than $25 million to provide critical clinical and translational research infrastructure and continue building collaborations across the University's campuses and with communities around the state. NCATS' CTSA Program develops innovative solutions to improve processes for turning laboratory, clinical and community research into health knowledge, interventions and treatments. CTSA institutions partner to advance biomedical and health research and share best practices and tools. Penn State is one of 64 funded CTSA organizations nationally and is among the few that serve primarily rural communities.
The global pandemic resulted in numerous changes in healthcare, both in terms of practice and behind-the-scenes procedures. As we head into the new normal where technology has become the way of life, healthcare organizations are rethinking their strategies, thus making artificial intelligence (AI) in healthcare and revenue cycle management a hot topic. It is no mystery that revenue cycle management has gotten more challenging. Increased patient financial responsibility, convoluted payer contracts, and the shift to value-based payments are just a few of the factors that make RCM more difficult. AI is no longer just a buzzword in the revenue cycle; it is a strategy leveraged to enhance the efficiency of RCM and the associated outcomes.
A massive disruption now appears imminent in one of the world's largest – and most important – industries. In much the same way that Amazon disrupted the retail business – and how PayPal disrupted the payments industry – one under-the-radar health technology company now seeks to transform the $11.85 trillion global health industry. By moving healthcare away from brick and mortar, traditional medicine into an AI-driven tool that offers unprecedented speed, efficiency, and accuracy... Investors still have a brief window of opportunity to get in on this transformational investment opportunity while it still flies beneath Wall Street's radar. But as you'll soon discover, this company's technology is so powerful that it could become a valuable addition to hundreds of millions of households worldwide. Whether most patients, providers, or large healthcare companies realize it or not, the healthcare industry is already in the early stages of significant change. That's because patients now desire access to more information – and better information – in the blink of an eye. In a recent survey of U.S. health consumers, 71% reported facing major frustrations through their experience with healthcare providers. Concerns ranged from difficulties scheduling appointments to impersonal visits.
While the pandemic is still raging, the chaos of the past 18 months has calmed a bit, and the dust is starting to settle. Now the time has come for healthcare CIOs and other health IT leaders to look forward and plan their IT investments – shaped, in no small part, by the lessons of the recent past. According to new research from HIMSS Media, the average overall 2021 IT budget is nearly $13 million, with 15% on average being allocated to IT security. While that may be a lot of money, there are many technological areas yearning for more investment. Today, Healthcare IT News launches a new feature article series, Health IT Investment: The Next Five Years.
Singapore's public sector has kicked off 5G pilots involving uses cases for various industries, including healthcare, manufacturing, and construction. The government is targeting to run 15 live trials on the southern island of Sentosa by yer-end, before ramping this figure up to at least 30 by the first half of 2023. The first set of 10 already had started at Sentosa, with multiple agencies including the Building and Construction Authority (BCA), National Environment Agency (NEA) and Centre for Healthcare Assistive and Robotics Technologies (Chart) under Changi General Hospital. These trials would see the use of 5G for autonomous robots, tele-operated vehicles, and augment reality applications, according to Government Technology Agency (GovTech), which is the public sector's CIO. Industry regulator Infocomm Media Development Authority has set aside S$40 million (US$29.53 million) to support research and development efforts and drive adoption of 5G, which include initiatives focused on key verticals such as urban mobility and maritime.
Published 5 Oct. 2021 By Kicky van Leeuwen In the application of AI in healthcare, we still have a hard nut to crack. Who is going to pay - and how much - for AI in healthcare? Technological advancements in healthcare have raised our standard of care, but at the same time raised the costs to deliver that care. A recent Dutch report concluded that the net effect of technological innovation in healthcare is cost increasing, which is also confirmed by a report from the OECD. These results force us to be critical about the added value of any new technology we bring in, also AI. So how do we assess the value of AI (or well, any innovation really)?